Search

Your search keyword '"Nagel, Inga"' showing total 273 results

Search Constraints

Start Over You searched for: Author "Nagel, Inga" Remove constraint Author: "Nagel, Inga"
273 results on '"Nagel, Inga"'

Search Results

4. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

6. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features

7. CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum

11. MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

13. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma

17. The genomic and transcriptional landscape of primary central nervous system lymphoma

19. Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models.

22. SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis

25. The landscape of genomic alterations across childhood cancers

28. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations

31. Position effects at the FGF8 locus are associated with femoral hypoplasia

33. A familial disorder of altered DNA-methylation

35. Partially Levodopa‐Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.

36. Molecular characterization of Burkitt lymphoma in the breast or ovary

38. The landscape of genomic alterations across childhood cancers

42. BTK acts as a modulator of the response to imatinib in chronic myeloid leukemia.

44. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

46. IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

47. UBTF::ATXN7L3gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

48. IG‐MYC ‐positive leukemia and lymphoma with precursor B‐cell phenotype are genetically and epigenetically distinct from Burkitt lymphomas

49. The landscape of genomic alterations across childhood cancers

Catalog

Books, media, physical & digital resources